Found: 15
Select item for more details and to access through your institution.
Peripheral blood CD4<sup>+</sup>CCR6<sup>+</sup> compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03315-x
- By:
- Publication type:
- Article
Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial.
- Published in:
- PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0295838
- By:
- Publication type:
- Article
Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral Therapy.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0055038
- By:
- Publication type:
- Article
Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023).
- Published in:
- NeuroImmune Pharmacology & Therapeutics, 2024, v. 3, n. 1, p. 61, doi. 10.1515/nipt-2023-0025
- By:
- Publication type:
- Article
The cascade of care for patients with chronic hepatitis delta in Southern Stockholm, Sweden for the past 30 years.
- Published in:
- Liver International, 2024, v. 44, n. 1, p. 228, doi. 10.1111/liv.15770
- By:
- Publication type:
- Article
Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection.
- Published in:
- Life Science Alliance, 2022, v. 5, n. 9, p. 1, doi. 10.26508/lsa.202201405
- By:
- Publication type:
- Article
Incidence and severity of COVID‐19 in adults with and without HIV diagnosis.
- Published in:
- Journal of Internal Medicine, 2022, v. 292, n. 1, p. 168, doi. 10.1111/joim.13481
- By:
- Publication type:
- Article
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 4, p. 349, doi. 10.1007/s00228-009-0763-z
- By:
- Publication type:
- Article
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV.
- Published in:
- NPJ Biofilms & Microbiomes, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41522-023-00461-w
- By:
- Publication type:
- Article
Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
- Published in:
- HIV Medicine, 2022, v. 23, n. 8, p. 895, doi. 10.1111/hiv.13273
- By:
- Publication type:
- Article
Successful Combination Treatment for Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2011, v. 38, n. 6, p. 727, doi. 10.1007/s10928-011-9217-1
- By:
- Publication type:
- Article
IMPACT OF GUT MICROBIOTA ON IMMUNOGENICITY TO COVID-19 VACCINES IN PLWH.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 147
- By:
- Publication type:
- Article
HTLV in Sweden.
- Published in:
- AIDS Reviews, 2024, v. 26, n. 1, p. 41, doi. 10.24875/AIDSRev.24000002
- By:
- Publication type:
- Article
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 704, p. 1, doi. 10.1126/scitranslmed.adg9452
- By:
- Publication type:
- Article